Frontotemporal Lobar Degeneration

Frontotemporal lobar degeneration (FTLD) is distinct from Alzheimer's disease and other types of dementia due to its specific impact on the frontal and temporal lobes of the brain. Unlike Alzheimer's, which primarily affects memory, FTLD initially manifests with changes in personality, behavior, and language skills. These alterations often precede significant memory loss. FTLD encompasses several subtypes, each affecting different aspects of cognition and behavior. Unlike Alzheimer's, which is marked by the accumulation of amyloid plaques and tau protein tangles, FTLD is associated with abnormal deposits of proteins such as tau, TDP-43, or FUS. Understanding these distinctions is crucial for accurate diagnosis and treatment, as FTLD requires tailored management approaches distinct from those used for Alzheimer's disease and other forms of dementia.

Committee Members
Speaker at Alzheimer’s Disease, Dementia & Cognitive Disorders Conference 2027 - Jun Hua

Jun Hua

Johns Hopkins University , United States
Speaker at Alzheimer’s Disease, Dementia & Cognitive Disorders Conference 2027 - Nazneen N Dewji

Nazneen N Dewji

Cenna Biosciences Inc, United States
Speaker at Alzheimer’s Disease, Dementia & Cognitive Disorders Conference 2027 - Jacqueline London

Jacqueline London

Paris Diderot University, France
Tags

Submit your abstract Today

Whatsapp